Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers

William A. Palmisano, Kevin P. Crume, Marcie J. Grimes, Sally A. Winters, Minoru Toyota, Manel Esteller, Nancy Joste, Stephen B Baylin, Steven A. Belinsky

Research output: Contribution to journalArticle

Abstract

Aberrant methylation of 5′CpG islands is a key epigenetic event in many human cancers. A PCR-based technique of methylated CpG island amplification followed by representational difference analysis was used to identify genes methylated in cancer. Two of the CpG islands identified mapped to the 5′ untranslated region of the PAX5 α and β genes. These genes, located on chromosome 9p13, are transcribed from two distinct promoters and form two alternative first exons that are subsequently spliced to the common exons 2-10. The resulting splice variants encode two distinct transcription factors important in cell differentiation and embryonic development. Examination of the methylation status of each gene using methylation-specific PCR revealed that both genes are methylated in ∼65% of breast and lung tumors. Bisulfite sequencing revealed dense methylation patterns within each 5′CpG island, strongly correlating with transcriptional silencing. Expression in cell lines with dense methylation of either the PAX5 α or β promoter region was restored after treatment with the demethylating agent 5-Aza-2′-deoxycytidine. The PAX5 β gene encodes for the transcription factor B cell-specific activating protein that, in turn, directly regulates CD19, a gene shown to negatively control cell growth. A strong association was observed between PAX5 β methylation and loss of expression of the CD19 gene demonstrating that inactivation of the PAX5 β gene likely contributes to neoplastic development by inhibiting growth regulation through effects on CD19 gene expression. Recent studies have demonstrated the importance of PAX5 gene alterations in human cancer. Our results are the first to identify aberrant promoter methylation as a common mechanism for dysregulation of these genes in solid tumors.

Original languageEnglish (US)
Pages (from-to)4620-4625
Number of pages6
JournalCancer Research
Volume63
Issue number15
StatePublished - Aug 1 2003

Fingerprint

PAX5 Transcription Factor
Methylation
Genes
Neoplasms
CpG Islands
decitabine
Islands
Exons
Transcription Factors
B-Cell Activating Factor
Polymerase Chain Reaction
5' Untranslated Regions
Gene Silencing
Growth and Development
Genetic Promoter Regions
Epigenomics
Embryonic Development
Cell Differentiation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Palmisano, W. A., Crume, K. P., Grimes, M. J., Winters, S. A., Toyota, M., Esteller, M., ... Belinsky, S. A. (2003). Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. Cancer Research, 63(15), 4620-4625.

Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. / Palmisano, William A.; Crume, Kevin P.; Grimes, Marcie J.; Winters, Sally A.; Toyota, Minoru; Esteller, Manel; Joste, Nancy; Baylin, Stephen B; Belinsky, Steven A.

In: Cancer Research, Vol. 63, No. 15, 01.08.2003, p. 4620-4625.

Research output: Contribution to journalArticle

Palmisano, WA, Crume, KP, Grimes, MJ, Winters, SA, Toyota, M, Esteller, M, Joste, N, Baylin, SB & Belinsky, SA 2003, 'Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers', Cancer Research, vol. 63, no. 15, pp. 4620-4625.
Palmisano WA, Crume KP, Grimes MJ, Winters SA, Toyota M, Esteller M et al. Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. Cancer Research. 2003 Aug 1;63(15):4620-4625.
Palmisano, William A. ; Crume, Kevin P. ; Grimes, Marcie J. ; Winters, Sally A. ; Toyota, Minoru ; Esteller, Manel ; Joste, Nancy ; Baylin, Stephen B ; Belinsky, Steven A. / Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. In: Cancer Research. 2003 ; Vol. 63, No. 15. pp. 4620-4625.
@article{9c166c9f8f6a4827973a51e2e355077e,
title = "Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers",
abstract = "Aberrant methylation of 5′CpG islands is a key epigenetic event in many human cancers. A PCR-based technique of methylated CpG island amplification followed by representational difference analysis was used to identify genes methylated in cancer. Two of the CpG islands identified mapped to the 5′ untranslated region of the PAX5 α and β genes. These genes, located on chromosome 9p13, are transcribed from two distinct promoters and form two alternative first exons that are subsequently spliced to the common exons 2-10. The resulting splice variants encode two distinct transcription factors important in cell differentiation and embryonic development. Examination of the methylation status of each gene using methylation-specific PCR revealed that both genes are methylated in ∼65{\%} of breast and lung tumors. Bisulfite sequencing revealed dense methylation patterns within each 5′CpG island, strongly correlating with transcriptional silencing. Expression in cell lines with dense methylation of either the PAX5 α or β promoter region was restored after treatment with the demethylating agent 5-Aza-2′-deoxycytidine. The PAX5 β gene encodes for the transcription factor B cell-specific activating protein that, in turn, directly regulates CD19, a gene shown to negatively control cell growth. A strong association was observed between PAX5 β methylation and loss of expression of the CD19 gene demonstrating that inactivation of the PAX5 β gene likely contributes to neoplastic development by inhibiting growth regulation through effects on CD19 gene expression. Recent studies have demonstrated the importance of PAX5 gene alterations in human cancer. Our results are the first to identify aberrant promoter methylation as a common mechanism for dysregulation of these genes in solid tumors.",
author = "Palmisano, {William A.} and Crume, {Kevin P.} and Grimes, {Marcie J.} and Winters, {Sally A.} and Minoru Toyota and Manel Esteller and Nancy Joste and Baylin, {Stephen B} and Belinsky, {Steven A.}",
year = "2003",
month = "8",
day = "1",
language = "English (US)",
volume = "63",
pages = "4620--4625",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers

AU - Palmisano, William A.

AU - Crume, Kevin P.

AU - Grimes, Marcie J.

AU - Winters, Sally A.

AU - Toyota, Minoru

AU - Esteller, Manel

AU - Joste, Nancy

AU - Baylin, Stephen B

AU - Belinsky, Steven A.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Aberrant methylation of 5′CpG islands is a key epigenetic event in many human cancers. A PCR-based technique of methylated CpG island amplification followed by representational difference analysis was used to identify genes methylated in cancer. Two of the CpG islands identified mapped to the 5′ untranslated region of the PAX5 α and β genes. These genes, located on chromosome 9p13, are transcribed from two distinct promoters and form two alternative first exons that are subsequently spliced to the common exons 2-10. The resulting splice variants encode two distinct transcription factors important in cell differentiation and embryonic development. Examination of the methylation status of each gene using methylation-specific PCR revealed that both genes are methylated in ∼65% of breast and lung tumors. Bisulfite sequencing revealed dense methylation patterns within each 5′CpG island, strongly correlating with transcriptional silencing. Expression in cell lines with dense methylation of either the PAX5 α or β promoter region was restored after treatment with the demethylating agent 5-Aza-2′-deoxycytidine. The PAX5 β gene encodes for the transcription factor B cell-specific activating protein that, in turn, directly regulates CD19, a gene shown to negatively control cell growth. A strong association was observed between PAX5 β methylation and loss of expression of the CD19 gene demonstrating that inactivation of the PAX5 β gene likely contributes to neoplastic development by inhibiting growth regulation through effects on CD19 gene expression. Recent studies have demonstrated the importance of PAX5 gene alterations in human cancer. Our results are the first to identify aberrant promoter methylation as a common mechanism for dysregulation of these genes in solid tumors.

AB - Aberrant methylation of 5′CpG islands is a key epigenetic event in many human cancers. A PCR-based technique of methylated CpG island amplification followed by representational difference analysis was used to identify genes methylated in cancer. Two of the CpG islands identified mapped to the 5′ untranslated region of the PAX5 α and β genes. These genes, located on chromosome 9p13, are transcribed from two distinct promoters and form two alternative first exons that are subsequently spliced to the common exons 2-10. The resulting splice variants encode two distinct transcription factors important in cell differentiation and embryonic development. Examination of the methylation status of each gene using methylation-specific PCR revealed that both genes are methylated in ∼65% of breast and lung tumors. Bisulfite sequencing revealed dense methylation patterns within each 5′CpG island, strongly correlating with transcriptional silencing. Expression in cell lines with dense methylation of either the PAX5 α or β promoter region was restored after treatment with the demethylating agent 5-Aza-2′-deoxycytidine. The PAX5 β gene encodes for the transcription factor B cell-specific activating protein that, in turn, directly regulates CD19, a gene shown to negatively control cell growth. A strong association was observed between PAX5 β methylation and loss of expression of the CD19 gene demonstrating that inactivation of the PAX5 β gene likely contributes to neoplastic development by inhibiting growth regulation through effects on CD19 gene expression. Recent studies have demonstrated the importance of PAX5 gene alterations in human cancer. Our results are the first to identify aberrant promoter methylation as a common mechanism for dysregulation of these genes in solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=0043136717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043136717&partnerID=8YFLogxK

M3 - Article

C2 - 12907641

AN - SCOPUS:0043136717

VL - 63

SP - 4620

EP - 4625

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 15

ER -